Hepatitis associated with iproniazid (Marsilid®)
- 17 Downloads
The case histories of 3 patients who developed hepatitis with jaundice while taking iproniazid have been described. It is suggested that it might be wiser for the present not to use the drug in any patient with liver disease or impaired hepatic function. It is also recommended that the dose of the drug be reduced as rapidly as possible to the lowest level consistent with adequate clinical maintenance and that it be used for the shortest time possible.
KeywordsPublic Health Hepatitis Liver Disease Case History Hepatic Function
Unable to display preview. Download preview PDF.
- 1.Selikoff, I. J., Robitzek, E. H., andOrnstein, G. G. Treatment of pulmonary tuberculosis with hydrazide derivatives of isonicotinic acid.J.A.M.A. 150:973, 1952.Google Scholar
- 3.Bosworth, D. M.,et al. The use of iproniazid in the treatment of bone and joint tuberculosis.J. Bone & Joint Surg. 35:577, 1953.Google Scholar
- 4.Bosworth, D. M.,et al. Use of iproniazid in non-tuberculous bone and joint infections.J.A.M.A. 157:132, 1955.Google Scholar
- 6.de Verteuil, R. L., andLehmann, H. E. Therapeutic trial of iproniazid (Marsilid) in depressed and apathetic patients.Canad. M. A. J. 78:131, 1958.Google Scholar
- 7.Zetzel, L., andKaplan, H. Liver damage concurrent with iproniazid administration.New England J. Med. 258:1209, 1958.Google Scholar
- 8.Frantz, A. G. Fatal jaundice associated with iproniazid (Marsilid) therapy.J.A.M.A. 167:987, 1958.Google Scholar
- 9.Zeller, E. A., andBarsky, J. In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropyl hydrazine.Proc. Soc. Exper. Biol. & Med. 81:459, 1952.Google Scholar
- 10.Spector, S.,et al. Effect of iproniazid on brain levels of norepinephrine and serotonin.Science 127:704, 1958.Google Scholar
- 12.Popper, H. Anatomy of the intraphepatic biliary system and the pathogenesis of intrahepatic cholestatic jaundice.Gastroenterology 34:1028, 1958.Google Scholar